LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Cutaneous extramedullary hematopoiesis in a patient with secondary myelofibrosis due to MPL gene mutation

Photo by atikahakhtar from unsplash

Dermal extramedullary hematopoiesis (EMH) is seen as a normal process from the first to the fifth month of gestation, and it is a process in which undifferentiated dermal mesenchymal cells… Click to show full abstract

Dermal extramedullary hematopoiesis (EMH) is seen as a normal process from the first to the fifth month of gestation, and it is a process in which undifferentiated dermal mesenchymal cells retain their hematopoietic potential.1 However, after sixth months of gestation, hematopoiesis does not occur in the dermis except in a few conditions, such as in myeloproliferative disorders.1-3.

Keywords: hematopoiesis; patient secondary; secondary myelofibrosis; hematopoiesis patient; cutaneous extramedullary; extramedullary hematopoiesis

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.